-
Je něco špatně v tomto záznamu ?
Macrotroponins cause discrepancy in high-sensitivity examination
P. Broz, J. Racek, P. Prokop, J. Novak, D. Rajdl, L. Trefil
Jazyk angličtina Země Česko
Typ dokumentu kazuistiky, časopisecké články
NLK
Directory of Open Access Journals
od 2001
Free Medical Journals
od 1998
Medline Complete (EBSCOhost)
od 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
PubMed
36628561
DOI
10.5507/bp.2023.001
Knihovny.cz E-zdroje
- MeSH
- biologické markery krev MeSH
- lidé středního věku MeSH
- lidé MeSH
- senioři MeSH
- troponin I * krev MeSH
- troponin T * krev MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
AIM: We present two cases with clearly discrepant results of clinical examination and cardiac troponin I (cTnI) and cardiac troponin T (cTnT) concentrations. In similar cases with discrepant results, the possibility of interference should be considered. METHODS: Due to the suspicion of the presence of macrotroponin I in both of the presented cases, the patients were invited to our laboratory and both cTnI (Architect i1000, Abbott) and cTnT (Cobas 8000, Roche) concentrations were analysed. The samples were treated by preincubation in a heterophilic antibodies blocking tube (HBT) and analysed. Precipitation with polyethylene glycol solution (PEG) and molecular weight separation by gel filtration on Sephadex G100 was performed and concentrations of cTnI were analysed. RESULTS: In the same blood sample, the cTnT and cTnI concentrations were 7 and 1782 ng/L, respectively, in Case 1, and 6 and 96 ng/L, respectively, in Case 2. Incubation of samples in HBT had no significant effect. CTnI concentrations after precipitation with PEG - presented as the percentage of initial concentrations - were 7.4% in Case 1 (and 26.8% in the control sample) and 1.4% in Case 2 (and 56.0% in the control sample). These results indicate a significant decrease in both cases, supporting presence of macrotroponin I. Finally, analyses of cTnI concentrations after gel filtration also supported the presence of macrotroponin I. CONCLUSION: The present cases show that the presence of macrotroponin can lead to unnecessary investigation of the patient. When the possibility of interference is suspected, cooperation with laboratory staff to help with interpretation or to perform more detailed analysis is crucial.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24011933
- 003
- CZ-PrNML
- 005
- 20250507135909.0
- 007
- ta
- 008
- 240711s2024 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2023.001 $2 doi
- 035 __
- $a (PubMed)36628561
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Brož, Pavel $u Institute of Clinical Biochemistry and Haematology, University Hospital in Pilsen, Pilsen, Czech Republic $u Department of Sports Medicine, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic $7 xx0129416
- 245 10
- $a Macrotroponins cause discrepancy in high-sensitivity examination / $c P. Broz, J. Racek, P. Prokop, J. Novak, D. Rajdl, L. Trefil
- 520 9_
- $a AIM: We present two cases with clearly discrepant results of clinical examination and cardiac troponin I (cTnI) and cardiac troponin T (cTnT) concentrations. In similar cases with discrepant results, the possibility of interference should be considered. METHODS: Due to the suspicion of the presence of macrotroponin I in both of the presented cases, the patients were invited to our laboratory and both cTnI (Architect i1000, Abbott) and cTnT (Cobas 8000, Roche) concentrations were analysed. The samples were treated by preincubation in a heterophilic antibodies blocking tube (HBT) and analysed. Precipitation with polyethylene glycol solution (PEG) and molecular weight separation by gel filtration on Sephadex G100 was performed and concentrations of cTnI were analysed. RESULTS: In the same blood sample, the cTnT and cTnI concentrations were 7 and 1782 ng/L, respectively, in Case 1, and 6 and 96 ng/L, respectively, in Case 2. Incubation of samples in HBT had no significant effect. CTnI concentrations after precipitation with PEG - presented as the percentage of initial concentrations - were 7.4% in Case 1 (and 26.8% in the control sample) and 1.4% in Case 2 (and 56.0% in the control sample). These results indicate a significant decrease in both cases, supporting presence of macrotroponin I. Finally, analyses of cTnI concentrations after gel filtration also supported the presence of macrotroponin I. CONCLUSION: The present cases show that the presence of macrotroponin can lead to unnecessary investigation of the patient. When the possibility of interference is suspected, cooperation with laboratory staff to help with interpretation or to perform more detailed analysis is crucial.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a troponin I $x krev $7 D019210
- 650 12
- $a troponin T $x krev $7 D020107
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a biologické markery $x krev $7 D015415
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Racek, Jaroslav, $d 1951- $u Institute of Clinical Biochemistry and Haematology, University Hospital in Pilsen, Pilsen, Czech Republic $u Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic $7 jn20000402090
- 700 1_
- $a Prokop, Pavel $u Institute of Clinical Biochemistry and Haematology, University Hospital in Pilsen, Pilsen, Czech Republic $7 xx0331798
- 700 1_
- $a Novák, Jaroslav, $d 1941- $u Department of Sports Medicine, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic $7 nlk20020105693
- 700 1_
- $a Rajdl, Daniel, $d 1977- $u Institute of Clinical Biochemistry and Haematology, University Hospital in Pilsen, Pilsen, Czech Republic $u Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic $7 xx0111616
- 700 1_
- $a Trefil, Ladislav $u Institute of Clinical Biochemistry and Haematology, University Hospital in Pilsen, Pilsen, Czech Republic $7 xx0099653
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1804-7521 $g Roč. 168, č. 2 (2024), s. 187-190
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36628561 $y Pubmed
- 910 __
- $a ABA008 $b A 1502 $c 958 $y p $z 0
- 990 __
- $a 20240711 $b ABA008
- 991 __
- $a 20250507135907 $b ABA008
- 999 __
- $a ok $b bmc $g 2316446 $s 1223785
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 168 $c 2 $d 187-190 $e 20230109 $i 1804-7521 $m Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $n Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub $x MED00012606
- LZP __
- $b NLK124 $a Pubmed-20240711